EGRP-Supported Epidemiology Consortia
Ovarian Cancer
- Evidence-based Network for the Interpretation of Germline Mutant Alleles Consortium (ENIGMA)
- Ovarian Cancer Association Consortium (OCAC)
- Ovarian Cancer Cohort Consortium (OC3)
- Pacific Ovarian Cancer Research Consortium (POCRC)
- Prevention and Observation of Surgical Endpoints and Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers (PROSE-Modifiers Studies) (Collaborative Studies of BRCA 1/2 Mutation Carriers)
Evidence-based Network for the Interpretation of Germline Mutant Alleles Consortium (ENIGMA) - Consortium Web Site![]() |
||
|---|---|---|
| Since 2009 | NIH Contacts: | |
|
EGRP/NCI: Scientific Consortia Coordinator & Consortia Fellow: |
Lead Investigator: David Goldgar, Ph.D. |
|
- View active grants and publications
related to the Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Consortium
Ovarian Cancer Association Consortium (OCAC) - Consortium Web Site![]() |
||
|---|---|---|
| Since 2005 | NIH Contacts: | |
![]() |
EGRP/NCI: Scientific Consortia Coordinator & Consortia Fellow: |
Lead Investigator: Andrew Berchuck, M.D. |
- View active grants and publications
related to the Ovarian Cancer Association Consortium (OCAC)
| Ovarian Cancer Cohort Consortium (OC3) | ||
|---|---|---|
| Since 2009 | NIH Contacts: | |
|
EGRP/NCI: OC3 Liaison: Scientific Consortia Coordinator: Consortia Fellow: DCEG/NCI: Nicolas Wentzensen, M.D., Ph.D. |
Lead Investigators: Shelley Tworoger, Ph.D. Alan Arslan, M.D. |
|
- View active grants and publications
related to the Ovarian Cancer Cohort Consortium (OC3)
Pacific Ovarian Cancer Research Consortium (POCRC) - Consortium Web Site![]() |
||
|---|---|---|
| Since 1999 | NIH Contacts: | |
![]() |
EGRP/NCI: Scientific Consortia Coordinator & Consortia Fellow: |
Lead Investigator: Nicole Urban, Ph.D. |
- View active grants and publications
related to the Pacific Ovarian Cancer Research Consortium (POCRC)
Prevention and Observation of Surgical Endpoints and Modifiers of Cancer Risk in BRCA 1/2 Mutation Carriers (PROSE-Modifiers Studies) (Collaborative Studies of BRCA 1/2 Mutation Carriers) - Consortium Web Site![]() |
||
|---|---|---|
| NIH Contacts: | ||
![]() |
EGRP/NCI: Scientific Consortia Coordinator & Consortia Fellow: |
Lead Investigators: Timothy Rebbeck, Ph.D. |
- View active grants and publications
related to the Prevention and Observation of Surgical Endpoints and Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers (PROSE-Modifiers Studies)
| Key to Acronyms Used in Tables | |
|---|---|
| EGRP | Epidemiology and Genomics Research Program |
| CDC | Centers for Disease Control and Prevention |
| DCB | Division of Cancer Biology |
| DCEG | Division of Cancer Epidemiology and Genetics |
| NCI | National Cancer Institute |
| NHGRI | National Human Genome Research Institute |
| NIEHS | National Institute of Environmental Health Sciences |
| NIH | National Institutes of Health |
| OCS | Office of Cancer Survivorship |
| OD | Office of the Director |


